amphetamine has been researched along with Acquired Immunodeficiency Syndrome in 6 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two intravenous amphetamine abusers had fatal, rapidly progressive cerebral mucormycosis with abscess formation in the presence of absolute lymphopenia." | 7.67 | Intravenous amphetamine abuse, primary cerebral mucormycosis, and acquired immunodeficiency. ( Micozzi, MS; Wetli, CV, 1985) |
| "Two intravenous amphetamine abusers had fatal, rapidly progressive cerebral mucormycosis with abscess formation in the presence of absolute lymphopenia." | 3.67 | Intravenous amphetamine abuse, primary cerebral mucormycosis, and acquired immunodeficiency. ( Micozzi, MS; Wetli, CV, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ananda, S | 1 |
| Shaohua, Z | 1 |
| Fan, Y | 1 |
| Liang, L | 1 |
| Chruściel, TL | 1 |
| Käll, KI | 2 |
| Olin, RG | 1 |
| Pohl, P | 1 |
| Vogl, G | 1 |
| Fill, H | 1 |
| Rössler, H | 1 |
| Zangerle, R | 1 |
| Gerstenbrand, F | 1 |
| Micozzi, MS | 1 |
| Wetli, CV | 1 |
1 review available for amphetamine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
HIV-negative drug addict diagnosed with AIDS and tuberculosis at autopsy: a case report and brief review of literature.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphetamine; Autop | 2011 |
5 other studies available for amphetamine and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
[Drug abuse in 1997 in Poland].
Topics: Acquired Immunodeficiency Syndrome; Amphetamine; Cocaine; Hallucinogens; Humans; Incidence; Narcotic | 1997 |
Effects of amphetamine on sexual behavior of male i.v. drug users in Stockholm--a pilot study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphetamine; Attitude to Health; Humans; Libido; Male; Mi | 1992 |
HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphetamine; Behavior; Female; Heroin; HIV Seroprevalence | 1990 |
Single photon emission computed tomography in AIDS dementia complex.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphetamine; Brain; Dementia; Diagnosis, Differential; El | 1988 |
Intravenous amphetamine abuse, primary cerebral mucormycosis, and acquired immunodeficiency.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphetamine; Brain; Brain Abscess; Female; Forensic Medic | 1985 |